This also suggests that RB1/p53 inactivation is likely an important early event underlying SCLC transformation, although it is important to note that the majority of EGFR/RB1/p53-mutant NSCLC tumors do not undergo SCLC transformation [13], highlighting the importance of other molecular drivers. The gene discussed is RB1; the disease is small cell lung carcinoma.